EMS was categorized as myeloid/lymphoid neoplasms with FGFR1 rearrangement in the 2017 revision of the World Health Organization classification of myeloid neoplasms and acute leukemia [10]. The gene discussed is FGFR1; the disease is lymphoid neoplasm.